Sign in

CIK 0001570562 · Accelerated filer

Evolus, Inc.

Sign in to watch
Ticker
EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
461385614
Phone
(949) 284-4555
Business address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
Former names
Evolus, Inc.
  1. 8-K Event Executive or director change · Regulation FD disclosure
  2. 8-K Event Results of operations
  3. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 8-K Event Regulation FD disclosure
  6. 4 Grant or award Director acquired 19,313 shares (grant or award)
  7. 4 Grant or award Director acquired 19,313 shares (grant or award)
  8. 4 Grant or award Director acquired 19,313 shares (grant or award)
  9. 4 Grant or award Director acquired 19,313 shares (grant or award)
  10. 4 Grant or award Director acquired 19,313 shares (grant or award)
  11. 4 Grant or award Director acquired 19,313 shares (grant or award)
  12. 4 Grant or award See Remarks acquired 45,000 shares (grant or award)
  13. 4 Grant or award See Remarks acquired 90,000 shares (grant or award)
  14. 4 Grant or award See Remarks acquired 90,000 shares (grant or award)
  15. 4 Grant or award See Remarks acquired 266,667 shares (grant or award)
  16. 4 Open-market sale See Remarks sold 2,699 shares at $7.46 ($20,135)
  17. 4 Open-market sale See Remarks sold 2,699 shares at $7.46 ($20,135)
  18. 4 Open-market sale See Remarks sold 2,699 shares at $7.46 ($20,135)
  19. 4 Open-market sale See Remarks sold 8,310 shares at $7.46 ($61,993)
  20. 8-K Event Agreement ended · Results of operations

Page 18 of 28 · 558 filings